Skip to main content
Premium Trial:

Request an Annual Quote

Less Drama, More Realism

King's College London sociologists Claire Marris and Nikolas Rose work with synthetic biologists at the Centre for Synthetic Biology and Innovation, and they write in New Scientist that it's time to have a real discussion about the pros and cons of synthetic biology, without the accompanying Sturm und Drang. Synthetic biology is "exciting but terrifying. Powerful but scary," they write. The field has "ambitious" goals to produce a relatively easy-to-use toolbox of synthetic parts that can be used to build organisms for varying purposes, they add, but, right now, these are still only goals.

Unfortunately, the dialogue surrounding synthetic biology assumes that these goals have already been met, and focus only on the possible misuses of the technology, Marris and Rose write. "This way of framing discussions is unhelpful," they add. "It is an example of 'speculative ethics' that distracts us from less exciting but more pressing questions." Instead, discussions about synthetic biology should go beyond this and seek to recognize that "the prospects for synthetic biology are likely to be both less sensational and less forbidding than is generally acknowledged," they say.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.